<HashMap><database>ENA</database><scores/><additional><omics_type>Genomics</omics_type><center_name>Internal Medicine, Toho University</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA358510</full_dataset_link><scientific_name>Homo sapiens</scientific_name><tag>xref:PubMed:29404483</tag><long_description>Among all the evaluated factors, only adipose tissue insulin sensitivity (assessed by clamped % suppression of serum free fatty acid), serum concentration of high molecular weight adiponectin, and plasma concentration of TCA cycle metabolites such as citric acid and cis-aconitic acid (assessed by metabolome analysis), associated significantly and positively with hepatic insulin sensitivity in NAFLD. Overall design: We analyzed the data to identify factors associated with preserved hepatic insulin sensitivity despite of hepatic steatosis. The 26 NAFLD patients with intrahepatic lipid content of >5% were divided into three groups according to the level of hepatic insulin sensitivity, as assessed by clamped % suppression of endogenous glucose production. Then, all the evaluated factors were compared between the hepatic insulin sensitive and resistant patients with comparable hepatic steatosis (n=9 vs 8, respectively).</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Homo sapiens</name><description>Identify factors associated with preserved hepatic insulin sensitivity despite of hepatic steatosis.</description><dates><last_updated>2025-09-24</last_updated><first_public>2017-04-19</first_public></dates><accession>PRJNA358510</accession><cross_references><GEO>GSE92746</GEO><taxon>9606</taxon><PubMed>29404483</PubMed></cross_references></HashMap>